Business Context and Reporting Period
Company: cbdMD, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: May 15, 2019
Event: Closing of a previously announced firm commitment underwriting public offering.
Exchange: NYSE American (Symbol: YCBD)
Key Financial Metrics
This filing is a current report regarding a corporate event and does not contain audited financial statements, revenue figures, profit margins, cash flow data, debt levels, or liquidity metrics. The filing text does not provide a clear value for these financial indicators.
Material Changes
The primary material change reported is the successful closing of the firm commitment underwriting public offering. This event represents a significant capital raise for the company, though the specific amount raised is not detailed within the text of this 8-K form itself (referenced in the attached press release).
Guidance, Outlook, and Risks
Management Commentary: The filing confirms the execution of the offering but provides no forward-looking guidance, outlook, or specific management commentary beyond the announcement of the closing.
Risks and Contingencies: No specific risks or contingencies are detailed in this document. The company is identified as an "Emerging Growth Company" under Rule 405 of the Securities Act of 1933.
Investor Verification Checklist
- Verify the total gross proceeds and net proceeds from the public offering by reviewing the attached press release (Exhibit 99.1) or the related S-1/A filing.
- Confirm the number of shares issued and the offering price per share.
- Review the use of proceeds disclosed in the offering documents to understand capital allocation strategy.
- Check for any underwriting discounts or commissions that may impact net capital raised.